Concepedia

Olga Almacellas‐Rabaiget

OA

Statistics

Publications

5

Citations

171

H-Index

5

Active since

2016

Affiliations

Institut d'Investigació Biomédica de Bellvitge(Current)

Instituto de Salud Carlos III

University of Iowa

Institut Català d'Oncologia

Centro de Investigación Biomédica en Red de Cáncer

Olga Almacellas‐Rabaiget is an author at Institut d'Investigació Biomédica de Bellvitge specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2016–2023

5

Publications

5

EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

Sílvia García-Monclús, Roser López‐Alemany, Olga Almacellas‐Rabaiget et al. · International Journal of Cancer · 2018 · 61 citations · Full text

, , +17

Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway

Laura Lagares‐Tena, Sílvia García-Monclús, Roser López‐Alemany et al. · Oncotarget · 2016 · 46 citations · Full text

, , +14

DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1

Juan Huertas-Martínez, Franck Court, Santiago Rello‐Varona et al. · Cancer Letters · 2016 · 30 citations

, , +14

LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity

Olga Almacellas‐Rabaiget, Paola Monaco, Juan Huertas-Martínez et al. · Cancer Letters · 2020 · 20 citations

, , +15

Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors

Laura Santana-Viera, Justin P. Dassie, Marta Rosàs‐Lapeña et al. · Molecular Therapy — Nucleic Acids · 2023 · 14 citations · Full text

, , +15

1–5 of 5